Q/C Technologies, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
Q/C Technologies, Inc. (QCLS) reported Revenue from Contract with Customer, Excluding Assessed Tax of -$1.89 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2020-08-14
- Q/C Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2020-06-30 was -$1.89K, a 100.41% decline year-over-year.
- Q/C Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2020-03-31 was $363.51K, a 40.61% decline year-over-year.
- Q/C Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2019-12-31 was $79.58K, a 71.52% decline year-over-year.
- Q/C Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2019-09-30 was $420.81K, a 24.46% decline year-over-year.
- Q/C Technologies, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2018 was $1.67M, a 50.35% decline from fiscal 2017.
- Q/C Technologies, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2017 was $3.35M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2020-06-30 | -$1.89K 10-Q · filed 2020-08-14 | $361.63K 10-Q · filed 2020-08-14 | $441.21K derived: sum of 3 quarters · filed 2020-08-14 | $862.02K derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | $363.51K 10-Q · filed 2020-05-15 | $443.10K derived: sum of 2 quarters · filed 2020-08-14 | $863.91K derived: sum of 3 quarters · filed 2020-08-14 | $1.33M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-12-31 | $79.58K derived: 10-Q 12 month − 10-Q 9 month · filed 2020-08-14 | $500.40K derived: sum of 2 quarters · filed 2020-08-14 | $964.91K derived: sum of 3 quarters · filed 2020-08-14 | $1.58M 10-Q · filed 2020-08-14 |
| 2019-09-30 | $420.81K 10-Q · filed 2019-11-14 | $885.33K derived: sum of 2 quarters · filed 2020-08-14 | $1.50M 10-Q · filed 2019-11-14 | $1.78M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-06-30 | $464.51K 10-Q · filed 2020-08-14 | $1.08M 10-Q · filed 2020-08-14 | $1.36M derived: sum of 3 quarters · filed 2020-08-14 | $1.91M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $612.12K 10-Q · filed 2020-05-15 | $891.53K derived: sum of 2 quarters · filed 2020-05-15 | $1.45M derived: sum of 3 quarters · filed 2020-05-15 | $1.98M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $279.40K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $836.49K derived: sum of 2 quarters · filed 2020-03-25 | $1.36M derived: sum of 3 quarters · filed 2020-03-25 | $1.67M 10-K · filed 2020-03-25 |
| 2018-09-30 | $557.09K 10-Q · filed 2019-11-14 | $1.08M derived: sum of 2 quarters · filed 2019-11-14 | $1.39M 10-Q · filed 2019-11-14 | $2.32M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $526.60K 10-Q · filed 2019-08-14 | $829.08K 10-Q · filed 2019-08-14 | $1.77M derived: sum of 3 quarters · filed 2019-08-14 | $2.44M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $302.48K 10-Q · filed 2019-05-20 | $1.24M derived: sum of 2 quarters · filed 2019-05-20 | $1.92M derived: sum of 3 quarters · filed 2019-05-20 | $2.99M derived: sum of 4 quarters · filed 2019-05-20 |
| 2017-12-31 | $938.77K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.61M derived: sum of 2 quarters · filed 2019-04-01 | $2.69M derived: sum of 3 quarters · filed 2019-04-01 | $3.35M 10-K · filed 2019-04-01 |
| 2017-09-30 | $675.83K 10-Q · filed 2018-11-14 | $1.75M derived: sum of 2 quarters · filed 2018-11-14 | $2.42M 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $1.07M 10-Q · filed 2018-08-14 | $1.74M 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |